Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

These 3 Companies Currently Provide Much Better Value Than Nio

By Will Ashworth, InvestorPlace Contributor
Nio stock is worth more than Daimler. It sells 1/200th the number of vehicles. Here are three companies that provide better value.

As It Flags in the 5G Race, Nokia Stock Is in for a Very Long Winter

By Muslim Farooque, InvestorPlace Contributor
Nokia stock is down this month on the back of a disappointing third quarter and its lacklustre performance in the 5G realm

Beyond Meat Stock Is Too High at 20 Times Revenue While Growth Stalls

By Mark R. Hake, CFA
Growth has slowed at Beyond Meat, so why is the stock valued like it's spiking? Beyond Meat stock is not worth its huge 20 times revenue multiples while its growth is slowing.

As Musk Battles the Coronavirus, It’s Time to Sell Tesla Stock

By Dana Blankenhorn, InvestorPlace Contributor
Elon Musk's Covid-19 diagnosis should remind investors that the biggest risk they face is his health. Take your profits in Tesla stock.

JFrog Is Still Wildly Overvalued Ahead of Insider Share Lockout Release

By Mark R. Hake, CFA
JFrog is still ridiculously overvalued ahead of its insider share lockout release. FROG stock is still trading for 29 times 2021 revenue forecasts, which is too high for most value investors.

5 Overvalued Stocks to Purge From Portfolios Before We Enter 2021

By Thomas Niel, InvestorPlace Contributor
Could these five overvalued stocks change course as the new year approaches? Consider selling BURL, CMG, PINS, RCL and W ahead of their likely declines.

7 Sin Stocks That May Face Coronavirus Headwinds

By Josh Enomoto, InvestorPlace Contributor
Given the narrative of stress release, sin stocks should perform well in this pandemic. But here are names that might struggle.

Sell Novavax Stock After Its Huge Gain

By Dana Blankenhorn, InvestorPlace Contributor
NVAX stock has a nearly $6 billion market cap based on a COVID-19 vaccine that may not work. The firm has a history of cashing in on hype.

Nikola Will Likely Keep On Losing Money, Pushing NKLA Stock Lower

By Mark R. Hake, CFA
Nikola will likely keep on losing money, pushing NKLA stock lower. It is worth over 8 times less based on its negative cash flow.

AT&T Stock’s Terrible Year Gets Slightly Better, But I Still Wouldn’t Buy It

By Louis Navellier and the InvestorPlace Research Staff
AT&T stock has performed better over the past two weeks, but there are many obstacles in the way of anything approaching a recovery.

Pass on Floundering Nokia Stock Despite Comeback Potential

By Thomas Niel, InvestorPlace Contributor
Don't count on a turnaround in 2021 for "also-ran" 5G play Nokia stock. But, don't expect shares to fall back to prior lows, either.

Inovio Has Little to Show for Its Covid-19 Efforts

By Mark R. Hake, CFA
Inovio Pharmaceuticals has little to show for its Covid-19 efforts. INO stock is not worth more than $2, according to one short-seller.

It’s Been a Great Run, but Now’s the Time to Take Profits in Walmart Stock

By Dana Blankenhorn, InvestorPlace Contributor
Walmart continues to find it hard to shift big numbers. Will investors really pay 24 times earnings for mid single-digit growth?

Can Delta Air Lines Benefit From the Lessons of 1918?

By Josh Enomoto, InvestorPlace Contributor
Initially, DAL stock might draw favorable comparisons to the railroad industry’s recover following the 1918 influenza pandemic. However, a closer inspection reveals that the two eras only look similar on the outside.

Hexo Stock Is a Losing Bet So Investors Should Short It

By Mark R. Hake, CFA
Hexo stock is a losing bet. Hexo stock won’t survive without further capital, providing investors a great shorting opportunity.

XPeng Might be at Full Value Unless Sales Surprise on the Upside

By Mark R. Hake, CFA
XPeng might be at full value unless sales surprise on the upside. XPEV stock trades at over 15 times estimated 2021 sales and looks fully valued here.

Make Ever-Glory International Give You a Reason to Buy its Stock

By Chris Markoch, InvestorPlace Contributor
EVK stock is up over 100% in the last month. The question is why. And if the answer is "because it's 2020", that's not a reason to buy it.

7 Top Airline Stocks To Sell That Just Can’t Get Airborne

By Louis Navellier and the InvestorPlace Research Staff
Despite positive vaccine news and the approaching holidays, this is not the time to be bottom fishing with these airline stocks to sell.

8 Overvalued Stocks to Sell in November

By Vince Martin, InvestorPlace Contributor
Overvalued stocks have led the market in recent years, while cheap stocks have lagged. Of late, that seems to be changing — which is bad news for these 8 names.
Load More Articles